Facebook: Analysts Expect $3.03 In Q2 Earnings Per Share

Facebook (NASDAQ: FB) will be reporting its second quarter financial results today after the markets close. Analysts have a consensus $391.39 12-month price target on the company, via a total of 55 analysts, with 19 analysts having strong buy ratings. 27 analysts meanwhile have buy ratings, 7 have hold ratings, and two analysts have sell ratings on the company. The street high comes from Credit Suisse with a $480 price target, and the lowest target sits at $225 from Societe Generale.

38 analysts have revenue estimates for the second quarter. The mean revenue estimate between all 38 analysts is $27.87 billion; this number has been revised upwards from $24.28 billion at the start of the year. The highest revenue estimate is $28.75 billion, while the lowest is $27 billion.

Onto EBITDA estimates, there are currently 25 analysts who have second-quarter EBITDA estimates. The mean is currently $14.48 billion, with this number having been revised upwards from $11.78 billion at the start of the year. The street high estimate currently sits at $15.59 billion in EBITDA and the lowest is $12.36 billion.

Analysts estimate that quarterly earnings per share will come in at $3.03, with this number being revised upwards from $2.31 at the start of the year. Street high is $3.41 and the lowest estimate is $2.36 per share for the quarter.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

8 Mining Stocks Our Viewers Asked Us to Review | Sept 14th-18th

Canada Is Finally Fast-Tracking New Mines | John Passalacqua – First Phosphate

Gold & Silver Just Added $2 Billion to This Project | Aya Gold – Bourmadine PEA

Recommended

Japan Gold Lands $50 Million in Committed Capital Through Solidcore Alliance

Blue Jay Gold Produces 66.9% Antimony Concentrate at 93.9% Recovery From Becker-Cochran

Related News

BofA: Shifts In Public Perception Driving Change [In Cannabis Legislation] Today

Yesterday, BofA Securities released a cannabis primer that largely focused on Canadian operators, such as...

Friday, December 4, 2020, 12:16:53 PM

Eldorado Gold: BMO Anticipates Gold Production Guidance Raise

On October 12th, Eldorado Gold (TSX: ELD) announced their third quarter 2021 preliminary production results....

Wednesday, October 20, 2021, 03:51:00 PM

Ayr Wellness: Fourth Quarter Consensus Estimates

Ayr Wellness (CSE: AYR.a) is set to report their fourth quarter and year end financials...

Wednesday, March 10, 2021, 11:51:00 AM

Cresco Labs: Analysts Raise Targets Following Blowout Quarter

On November 18th, Cresco Labs (CSE: CL) reported their third quarter financial results. The company...

Friday, November 20, 2020, 12:09:00 PM

Aphria: Consensus Estimates For Q3 2021

Aphria Inc (TSX: APHA) (NASDAQ: APHA) is expected to report their fiscal third quarter on...

Wednesday, April 7, 2021, 02:41:00 PM